SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-22-157549
Filing Date
2022-05-23
Accepted
2022-05-23 16:52:38
Documents
17
Period of Report
2022-05-20
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d334887d8k.htm   iXBRL 8-K 39037
2 EX-10.1 d334887dex101.htm EX-10.1 18792
3 EX-10.2 d334887dex102.htm EX-10.2 54747
4 EX-99.1 d334887dex991.htm EX-99.1 7269
8 GRAPHIC g334887g0520044512917.jpg GRAPHIC 4530
9 GRAPHIC g334887g0520045231739.jpg GRAPHIC 3750
  Complete submission text file 0001193125-22-157549.txt   287251

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA aclx-20220520.xsd EX-101.SCH 2845
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE aclx-20220520_lab.xml EX-101.LAB 18738
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE aclx-20220520_pre.xml EX-101.PRE 11700
11 EXTRACTED XBRL INSTANCE DOCUMENT d334887d8k_htm.xml XML 3467
Mailing Address 25 WEST WATKINS MILL ROAD SUITE A GAITHERSBURG MD 20878
Business Address 25 WEST WATKINS MILL ROAD SUITE A GAITHERSBURG MD 20878 240-723-6641
Arcellx, Inc. (Filer) CIK: 0001786205 (see all company filings)

IRS No.: 472855917 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41259 | Film No.: 22952467
SIC: 2836 Biological Products, (No Diagnostic Substances)